Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Contracts + Grants

    Oversight and Management of U.S. Army Chemical Research Repository

    By Global Biodefense StaffMay 23, 2013
    Share
    Facebook LinkedIn Reddit Email

    The U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research and Materiel Command (USAMRMC) drug discovery and development mission, is conducting market research to obtain and acquire information on the availability of companies who have the capability to provide the oversight and management of a chemical repository and associated chemical information systems.

    The principal objectives of the project are the receipt, storage, inventory, distribution, documentation, disposal, and control of synthetic compounds, natural products, bulk drugs and formulated drugs.

    The qualified contractor will provide personnel, facilities, equipment, materials and services to operate a chemical inventory laboratory for the receipt, storage and maintenance of approximately 500,000 chemical samples.

    Administration and maintenance of manual, digital, and imaged chemical information and inventory systems for the storage and retrieval of chemical sample data sheets, investigational new drug’s (IND’s), clinical protocols, and other documents is also required. 

    Contractor must have the capability to provide controlled cGMP inventory storage of preclinical and clinical lots of samples and of radiolabeled (14C and 3H) chemicals in accordance with appropriate local, state, and Federal Government regulations.

    Further details are available under Solicitation Number: W81XWH-13-S-0001. The response deadline is May 30, 2013.

    Share. Facebook LinkedIn Reddit Email
    Previous ArticleWHO Concerned About Poliovirus Outbreak in Horn of Africa
    Next Article Georgia Tech Research Suggests Drug Side Effects Are Inevitable

    Related Stories

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023

    Terrorism and the Pandemic: Weaponizing a Public Health Crisis

    September 20, 2023

    Mount Sinai to Lead Development of Pan-Coronavirus Vaccine Under New Federal Grant

    September 17, 2023

    NIAID Seeks to Improve Computational Models of Influenza Immunity

    September 15, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy